In a significant legal development, the U.S. Court of Appeals for the Tenth Circuit recently made a ruling that could reshape the future state regulation of pharmacy benefit managers (PBMs). The case in question, Pharmaceutical Care Management Association (PCMA) v. Mulready, was decided on August 15, 2023, and tackled the complex relationship between state authority and federal jurisdiction through the lens of the Employee Retirement Income Security Act (ERISA) and Medicare Part D.
Over the past few years, the power dynamic between state and federal authorities has been under intense scrutiny, particularly in the realm of healthcare regulation. This court decision is one of the first major interpretations since the U.S. Supreme Court expanded states’ authority with its Rutledge v. Pharmaceutical Care ruling. However, the Tenth Circuit, in its decision, has effectively countered this trend by upholding that ERISA and Medicare Part D do indeed preempt key components of the Oklahoma PBM law.
- The implications of this case are two-fold. On one hand, it offers legal clarity to PBMs, who, as part of the larger healthcare sector, have been grappling with the knotty tangles of regulation at different administrative levels. Simply put, the Circuit Court ruling delineates the regulatory perimeter more precisely, reducing unnecessary legal ambiguity. On the other hand, it underscores the ongoing tug of war between state and federal powers in the USA – a structural conflict that seems far from resolution.
- The ruling may affect the operation and regulation of PBMs across the United States, including other courts’ interpretations of ERISA’s preemptive effects on state laws, potentially directly impacting the way businesses approach compliance, policy development, and strategic planning.
- It is becoming increasingly evident that the judiciary will continue to play a major role in clarifying, drawing lines around, and defining the authority of state versus federal powers. Legal departments in major corporations and law firms would do well to stay tuned to this evolving landscape.
In concluding thoughts, the Tenth Circuit’s ruling is a reminder of the fact that legal interpretation often forms the frontline in the tug-of-war of jurisdiction between state and federal forces. A clearer understanding of such legal dynamics will play a significant role in the foreseen future for PBMs, moving them one step closer to more stable operation in the wake of the evolving healthcare regulation paradigm.